Drug Combo Marks Advance Against Bladder Cancer

MONDAY, March 11, 2024 -- A cancer drug duo more than doubled the survival of people battling the most common form of advanced bladder cancer, trial results show.Patients who took a combo of meds called EV+P -- enfortumab vedotin and pembrolizumab...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news